Page 7 - இரண்டாவது பார்வை மருத்துவ ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: Second Sight Medical Products (NASDAQ: EYES) shares are trading higher Tuesday after the company announced that it was issued a U.S. Patent for the uses of eye-tracking in a visual prosthesis. Second Sight Medical Products develops, manufactures and markets implantable prosthetic devices, to create an artificial form of useful vision for blind individuals. The company s product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. Second Sight Medical Products shares traded up 18.17% to $2.47. The stock has a 52-week high of $6.40 and a 52-week low of 69 cents. © 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Second sight medical productsSight medical productsRetinitis pigmentosaஇரண்டாவது பார்வை மருத்துவ ப்ராடக்ட்ஸ்பார்வை மருத்துவ ப்ராடக்ட்ஸ்